Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. - Lim JH; Mun SJ; Kang HM; Yu WD; Oh SJ; Lee JY; Son YS; Lee S; Kim DS; Lee J; Kim SJ; Cho HS; et al. (Signal transduction and targeted therapy, 2026)